On the stock market since 2013, it operates in the world of heavy industry. It has 58 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
The biggest line carries real weight, but it doesn’t decide everything on its own.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
The cash pile is strong; debt and other items pull the grade toward the middle.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Business Quality: Profit power and business quality trail similar companies in the sector.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
An investor who bought at the very peak is down 70% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $27.6M a year. A small number, but proof the product has real buyers.
There is $15.0M in the vault; even if every debt were paid off, $13.5M would remain.
Over the last 12 months, company executives reported 32 buys and 30 sells. Management buying with its own money is usually read as a good sign.
A loss of $6.4M against $27.6M in annual sales.
At the current pace of spending, the cash lasts about 2.3 years. After that, the company needs to find new money.
On our five-subject report card, PPSI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: PPSI is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (8/100) says the stock isn’t cheap.